Cargando…

Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes

PURPOSE: Evaluate long-term outcomes after one, two, or three trabecular micro-bypass stents implanted in a standalone procedure in eyes with open-angle glaucoma taking ocular hypotensive medication. PATIENTS AND METHODS: Prospective randomized ongoing study of 119 subjects (109 with 42-month follow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katz, L Jay, Erb, Carl, Carceller Guillamet, Amadeu, Fea, Antonio M, Voskanyan, Lilit, Giamporcaro, Jane Ellen, Hornbeak, Dana M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798569/ https://www.ncbi.nlm.nih.gov/pubmed/29440867 http://dx.doi.org/10.2147/OPTH.S152268

Ejemplares similares

Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication
por: Katz, L Jay, et al.
Publicado: (2015)

Implantation of two second‐generation trabecular micro‐bypass stents and topical travoprost in open‐angle glaucoma not controlled on two preoperative medications: 18‐month follow‐up
por: Berdahl, John, et al.
Publicado: (2017)

Outcomes Following Implantation of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication: 18-Month Follow-Up
por: Lindstrom, Richard, et al.
Publicado: (2016)

Efficacy of two trabecular micro-bypass stents combined with topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 3-year follow-up
por: Chang, David F, et al.
Publicado: (2017)

Effectiveness and Safety of iStent Infinite Trabecular Micro-Bypass for Uncontrolled Glaucoma
por: Sarkisian, Steven R., et al.
Publicado: (2023)

Prospective Evaluation of Two iStent(®) Trabecular Stents, One iStent Supra(®) Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes
por: Myers, Jonathan S., et al.
Publicado: (2018)

Prospective unmasked randomized evaluation of the iStent inject(®) versus two ocular hypotensive agents in patients with primary open-angle glaucoma
por: Fea, Antonio M, et al.
Publicado: (2014)

Outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic patient population
por: Gallardo, Mark J, et al.
Publicado: (2016)

Four-Year Outcomes of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication
por: Lindstrom, Richard, et al.
Publicado: (2020)

Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months
por: Vold, Steven D., et al.
Publicado: (2016)

Erratum to: Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months
por: Vold, Steven D., et al.
Publicado: (2016)

A prospective 3-year follow-up trial of implantation of two trabecular microbypass stents in open-angle glaucoma
por: Donnenfeld, Eric D, et al.
Publicado: (2015)

Prospective, Unmasked Evaluation of the iStent(®)Inject System for Open-Angle Glaucoma: Synergy Trial
por: Voskanyan, Lilit, et al.
Publicado: (2014)

Treatment Success Across Different Levels of Preoperative Disease Burden: Stratified Two-Year Outcomes from the Pivotal Trial of iStent inject(®) Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract
por: Singh, Inder Paul, et al.
Publicado: (2021)

Cost-utility analysis of trabecular micro-bypass stents (TBS) in patients with mild-to-moderate open-angle Glaucoma in Italy
por: Fea, Antonio Maria, et al.
Publicado: (2021)

The trabecular bypass stent in a pseudophakic glaucoma patient: A 1-year follow-up
por: Fea, Antonio M, et al.
Publicado: (2008)

iStent trabecular micro-bypass stent for open-angle glaucoma
por: Le, Kim, et al.
Publicado: (2014)

Detecting IOP Fluctuations in Glaucoma Patients
por: Nuyen, Brenda, et al.
Publicado: (2016)

Replacement of the Trabecular Meshwork Cells—A Way Ahead in IOP Control?
por: Fan, Xiaochen, et al.
Publicado: (2021)

Evaluation of Bleb Morphology and Reduction in IOP and Glaucoma Medication following Implantation of a Novel Gel Stent
por: Fea, Antonio Maria, et al.
Publicado: (2017)

Selective laser trabeculoplasty reduces mean IOP and IOP variation in normal tension glaucoma patients
por: El Mallah, Mohammed K, et al.
Publicado: (2010)

The IOP lowering effects of “planning” selective laser trabeculoplasty in open angle glaucoma
por: Chu, Yi-Ching, et al.
Publicado: (2022)

Ab interno canaloplasty combined with trabecular bypass stenting in eyes with primary open-angle glaucoma
por: Heersink, Marius, et al.
Publicado: (2019)

Open-Angle Glaucoma: Burden of Illness, Current Therapies, and the Management of Nocturnal IOP Variation
por: Sheybani, Arsham, et al.
Publicado: (2019)

Significance of non-intraocular pressure (IOP)-related factors particularly in normal tension glaucoma: Looking beyond IOP
por: Dinakaran, Shoruba, et al.
Publicado: (2022)

Combined iStent(®) Inject Trabecular Micro-Bypass and Phacoemulsification in Australian Patients with Open-Angle Glaucoma
por: Salby, Alon M, et al.
Publicado: (2020)

Osthole Reduces Mouse IOP Associated With Ameliorating Extracellular Matrix Expression of Trabecular Meshwork Cell
por: Fan, Yuchen, et al.
Publicado: (2020)

Innovative IOP-Independent Neuroprotection and Neuroregeneration Strategies in the Pipeline for Glaucoma
por: Tsai, James C.
Publicado: (2020)

A Cost-Utility Analysis of Trabecular Bypass Devices Versus Usual Care for Patients With Open-Angle Glaucoma
por: Healey, Paul R., et al.
Publicado: (2021)

Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension
por: Aihara, Makoto
Publicado: (2010)

Inter-eye correlation analysis of 24-h IOPs and glaucoma progression
por: Dakroub, Mohamad, et al.
Publicado: (2022)

Refractive Outcomes After Trabecular Micro-Bypass Stents (iStent Inject) with Cataract Extraction in Open-Angle Glaucoma
por: Ioannidis, Alexandros S, et al.
Publicado: (2020)

Atorvastatin reduces IOP in ocular hypertension in vivo and suppresses ECM in trabecular meshwork perhaps via FGD4
por: Song, Xiang-Yuan, et al.
Publicado: (2022)

Intracameral Injection of AAV-DJ.COMP-ANG1 Reduces the IOP of Mice by Reshaping the Trabecular Outflow Pathway
por: Qiao, Yunsheng, et al.
Publicado: (2022)

Fixed combination of bimatoprost and timolol in patients with primary open-angle glaucoma or ocular hypertension with inadequate IOP adjustment
por: Brief, Gerrett, et al.
Publicado: (2010)

Impact of Cataract Surgery on IOP and Ocular Structures in Normotensive Patients and Primary and Exfoliation Open-Angle Glaucoma Patients
por: Xirou, Vasiliki, et al.
Publicado: (2023)

Micro-Bypass Implantation for Primary Open-Angle Glaucoma Combined with Phacoemulsification: 4-Year Follow-Up
por: Fea, Antonio Maria, et al.
Publicado: (2015)

Self-measurement of IOP by patients with normal tension glaucoma before and after SLT
por: Young, Alexandra, et al.
Publicado: (2021)

Three-year outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic population with primary open-angle glaucoma
por: Gallardo, Mark J, et al.
Publicado: (2019)

Outcomes of Combined iStent Trabecular Micro-Bypass and Cataract Surgery for the Treatment of Open-Angle Glaucoma in a Saudi Population
por: Al Habash, Ahmed, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_40369cpsbk59fktvet6084gfus